Directory · 32 compounds

Every compound. Same scale.

32 compounds graded the same way — 21 of them are in the AERVYN range, carried by 24 pre-filled pens (4 of them blends). Each is assessed on one structured record: human evidence for every goal it has been researched for, regulatory status taken from our maintained database rather than inferred, published dosing research, safety and interactions. Where a compound is in the range — on its own pen or inside a blend — the card names the pen and its price.

Compounds
32
Families
8 of 8
Human studies recorded
64
In the AERVYN range
21
Database reviewed
26 Sept 2026

Showing 32 of 32

  • Growth hormone axis

    Tesamorelin

    Synthetic GHRH analogue

    Licensed GHRH analogue that reduces visceral fat in HIV-associated lipodystrophy

    Strong
    Not authorisedUK
    • Body composition
    • Longevity
    • +2
    • WADA prohibited

    £255 · In stock

    In the range · Tesamorelin

    Shop: Tesamorelin
  • Longevity & mitochondrial

    MOTS-c

    Mitochondrial-derived 16-amino-acid peptide

    Mitochondrial 'exercise mimetic' peptide: mouse data only, WADA-prohibited

    Insufficient
    Not authorisedUK
    • Longevity
    • Body composition
    • +1
    • WADA prohibited

    £255 · In stock

    In the range · MOTS-C

    Shop: MOTS-C
  • Skin, hair & cosmetic

    GHK-Cu

    Copper-binding tripeptide

    Topical copper peptide with modest cosmetic data; injectable use is untested

    Limited
    Not authorisedUK
    • Skin
    • Hair
    • +1

    £215 · In stock

    In the range · GHK-Cu

    Shop: GHK-Cu
  • Longevity & mitochondrial

    NAD+

    Coenzyme (not a peptide)

    Endogenous coenzyme; the human trials are of oral precursors, not injected NAD+

    Limited
    Not authorisedUK
    • Wellbeing
    • Longevity
    • +2

    £285 · In stock

    In the range · NAD+

    Shop: NAD+
  • Tissue repair

    BPC-157

    Synthetic pentadecapeptide

    Widely sold 'healing peptide' with animal data but no published human trials

    Insufficient
    Not authorisedUK
    • Injury
    • Muscle
    • +1
    • WADA prohibited

    £170 · In stock

    In the range · BPC-157

    Shop: BPC-157
  • Tissue repair

    TB-500

    Synthetic thymosin β4 fragment (residues 17–23)

    Thymosin β4 fragment sold for healing; no human trials of the fragment

    Insufficient
    Not authorisedUK
    • Injury
    • Muscle
    • +2
    • WADA prohibited

    £180 · In stock

    In the range · TB-500

    Shop: TB-500
  • Immune

    KPV

    Anti-inflammatory tripeptide (α-MSH fragment)

    α-MSH tripeptide with anti-inflammatory animal data and no human trials

    Insufficient
    Not authorisedUK
    • Skin
    • Injury
    • +1

    £175 · In stock

    In the range · KPV

    Shop: KPV
  • Metabolic (incretin-based)

    Retatrutide

    GIP/GLP-1/glucagon receptor triple agonist

    Investigational triple agonist with the largest trial weight loss reported so far

    Moderate
    InvestigationalUK
    • Weight
    • Body composition
    • +1

    £370 · In stock

    In the range · Retatrutide (R3T)

    Shop: Retatrutide (R3T)
  • Metabolic (incretin-based)

    Cagrilintide

    Long-acting amylin analogue

    Investigational weekly amylin analogue, studied alone and with semaglutide (CagriSema)

    Moderate
    InvestigationalUK
    • Weight
    • Body composition
    • +1

    £360 · In stock

    In the range · CagriSema (blend)

    Shop: CagriSema
  • Metabolic (incretin-based)

    Semaglutide

    GLP-1 receptor agonist

    Once-weekly incretin medicine with the largest weight-management evidence base

    Strong
    AuthorisedUK
    • Weight
    • Body composition
    • +2

    £265 · In stock

    In the range · Semaglutide

    Shop: Semaglutide
  • Growth hormone axis

    CJC-1295

    Long-acting GHRH analogue (albumin-binding)

    Long-acting GHRH analogue abandoned in development; sold as a research chemical

    Preliminary
    Not authorisedUK
    • Muscle
    • Body composition
    • +2
    • WADA prohibited

    £180 · In stock

    In the range · CJC-1295 (no DAC)

    Shop: CJC-1295 (no DAC)
  • Longevity & mitochondrial

    Epitalon

    Synthetic pineal-derived tetrapeptide

    'Telomerase-activating' longevity peptide with no controlled human trials

    Insufficient
    Not authorisedUK
    • Longevity
    • Sleep
    • +1

    £220 · In stock

    In the range · Epitalon

    Shop: Epitalon
  • Longevity & mitochondrial

    FOXO4-DRI

    FOXO4–p53 interfering peptide (D-retro-inverso)

    Designed senolytic peptide that rejuvenated aged mice; no human data of any kind

    Insufficient
    Not authorisedUK
    • Longevity
    • Wellbeing

    £330 · In stock

    In the range · FOXO4-DRI

    Shop: FOXO4-DRI
  • Sexual health

    Gonadorelin

    Gonadotropin-releasing hormone (GnRH) decapeptide

    Native GnRH: a licensed pituitary test and pump therapy, compounded off-label with testosterone

    Moderate
    AuthorisedUK
    • Sexual health
    • Wellbeing
    • +1
    • WADA prohibited

    £200 · In stock

    In the range · Gonadorelin

    Shop: Gonadorelin
  • Growth hormone axis

    Ipamorelin

    Selective ghrelin-receptor agonist (GH secretagogue pentapeptide)

    Selective GH secretagogue that failed its only published efficacy trial

    Preliminary
    Not authorisedUK
    • Muscle
    • Injury
    • +2
    • WADA prohibited

    £175 · In stock

    In the range · Ipamorelin

    Shop: Ipamorelin
  • Metabolic (incretin-based)

    Liraglutide

    GLP-1 receptor agonist

    Once-daily GLP-1 medicine with a decade of use and generic versions

    Strong
    AuthorisedUK
    • Weight
    • Body composition
    • +2

    £235 · In stock

    In the range · Liraglutide

    Shop: Liraglutide
  • Immune

    LL-37

    Human cathelicidin antimicrobial peptide (37 amino acids)

    Human antimicrobial peptide: topical wound trials only, injected use untested

    Preliminary
    Not authorisedUK
    • Injury
    • Wellbeing

    £200 · In stock

    In the range · LL-37

    Shop: LL-37
  • Sexual health

    PT-141 (bremelanotide)

    Melanocortin-4 receptor agonist

    FDA-approved on-demand injection for low sexual desire in premenopausal women

    Moderate
    Not authorisedUK
    • Sexual health
    • Weight
    • +1

    £195 · In stock

    In the range · PT-141

    Shop: PT-141
  • Growth hormone axis

    Sermorelin

    GHRH(1–29) fragment (growth-hormone-releasing hormone analogue)

    Formerly licensed GHRH fragment, now compounded for adult use with little evidence

    Limited
    Not authorisedUK
    • Longevity
    • Muscle
    • +2
    • WADA prohibited

    £190 · In stock

    In the range · Sermorelin

    Shop: Sermorelin
  • Immune

    Thymosin alpha-1

    Immunomodulatory thymic peptide (28 amino acids)

    Immune-modulating peptide medicine abroad; weak evidence for wellness use

    Moderate
    Not authorisedUK
    • Wellbeing
    • Longevity

    £210 · In stock

    In the range · Thymosin Alpha-1

    Shop: Thymosin Alpha-1
  • Metabolic (incretin-based)

    Tirzepatide

    Dual GIP/GLP-1 receptor agonist

    Once-weekly dual incretin with the largest weight loss among authorised medicines

    Strong
    AuthorisedUK
    • Weight
    • Body composition
    • +2

    £320 · In stock

    In the range · Tirzepatide

    Shop: Tirzepatide
  • Growth hormone axis

    Somatropin

    Recombinant human growth hormone

    Prescription growth hormone: proven for deficiency, weak and risky for enhancement

    Strong
    AuthorisedUK
    • Muscle
    • Body composition
    • +2
    • WADA prohibited

    Not in the AERVYN range

  • Metabolic (incretin-based)

    Survodutide

    Dual glucagon/GLP-1 receptor agonist

    Investigational weekly glucagon/GLP-1 dual agonist in phase 3 for obesity and MASH

    Moderate
    InvestigationalUK
    • Weight
    • Body composition
    • +1

    Not in the AERVYN range

  • Skin, hair & cosmetic

    Collagen peptides

    Oral hydrolysed collagen (food supplement)

    Oral food supplement with modest randomised-trial evidence for skin and joints

    Moderate
    Not authorisedUK
    • Skin
    • Injury
    • +2

    Not in the AERVYN range

  • Cognition, mood & sleep

    Selank

    Synthetic tuftsin-analogue heptapeptide

    Russian intranasal anxiolytic peptide with small, unreplicated trials

    Limited
    Not authorisedUK
    • Wellbeing
    • Sleep

    Not in the AERVYN range

  • Cognition, mood & sleep

    Semax

    Synthetic ACTH-fragment heptapeptide

    Russian intranasal 'nootropic' peptide; stroke data unreplicated abroad

    Limited
    Not authorisedUK
    • Wellbeing
    • Longevity

    Not in the AERVYN range

  • Longevity & mitochondrial

    Elamipretide

    Mitochondria-targeting tetrapeptide (cardiolipin binder)

    Mitochondrial peptide approved for one rare disease; negative trials elsewhere

    Limited
    Not authorisedUK
    • Longevity
    • Performance
    • +2

    Not in the AERVYN range

  • Sexual health

    Kisspeptin

    Hypothalamic neuropeptide (KISS1 receptor agonist)

    Investigational reproductive hormone studied for low desire and IVF, not a medicine

    Preliminary
    Not authorisedUK
    • Other
    • Sexual health
    • +1
    • WADA prohibited

    Not in the AERVYN range

  • Sexual health

    Melanotan II

    Non-selective melanocortin receptor agonist (α-MSH analogue)

    Unlicensed tanning and libido peptide that regulators have publicly warned against

    Preliminary
    Not authorisedUK
    • Skin
    • Sexual health
    • +1
    • WADA prohibited

    Not in the AERVYN range

  • Cognition, mood & sleep

    DSIP

    Endogenous neuropeptide (nonapeptide)

    1970s 'sleep peptide' with small, inconsistent human studies and no modern trials

    Preliminary
    Not authorisedUK
    • Sleep
    • Wellbeing

    Not in the AERVYN range

  • Growth hormone axis

    AOD-9604

    Synthetic C-terminal fragment of human growth hormone

    Failed obesity drug candidate now sold without authorisation; WADA-prohibited

    Insufficient
    Not authorisedUK
    • Body composition
    • Weight
    • +1
    • WADA prohibited

    Not in the AERVYN range

  • Growth hormone axis

    IGF-1 LR3

    Engineered IGF-1 analogue (laboratory reagent)

    Laboratory IGF-1 analogue with no human trials and serious hypoglycaemia risk

    Insufficient
    Not authorisedUK
    • Muscle
    • Performance
    • +2
    • WADA prohibited

    Not in the AERVYN range